Header Logo

Connection

Jonathan Wren to Neoplasm Proteins

This is a "connection" page, showing publications Jonathan Wren has written about Neoplasm Proteins.
Connection Strength

0.467
  1. KRCC1: A potential therapeutic target in ovarian cancer. FASEB J. 2020 02; 34(2):2287-2300.
    View in: PubMed
    Score: 0.157
  2. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06; 19(1):423.
    View in: PubMed
    Score: 0.150
  3. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1. J Clin Invest. 2016 Feb; 126(2):706-20.
    View in: PubMed
    Score: 0.119
  4. CSAG1 maintains the integrity of the mitotic centrosome in cells with defective p53. J Cell Sci. 2020 05 27; 133(10).
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.